Allen Northrup, PhD. was the Founder of Microfluidic Systems and Co-Founder of Cepheid (Nasdaq: CPHD).
He is currently the Science Advisor to 3 start-up companies in US and Europe.
Dr. Northrup earned his PhD in Biomedical Engineering from the University of California, Davis (UCD) in 1991. During his early years at UCD, Dr. Northrup worked for Finnigan Corporation, a manufacturer of Gas Chromatograph/Mass Spectrometers (GC/MS). As a Post-doctoral Fellow and Engineer at Lawrence Livermore National Laboratory (LLNL) and as a Visiting Scholar at the University of California, Berkeley (UCB), he was the first to demonstrate the Polymerase Chain Reaction (PCR) in a micro-machined silicon chip. At LLNL, he raised $12 M in funding and also invented and co-developed micro-actuators and micro-actuator materials, which includes over 30 patents.
As Co-Founder and CTO of Cepheid, he raised over $15M in R & D funding and was on the Initial Public Offering (IPO) team in FY 2000.
As CEO and Founder of Microfluidic Systems, Dr. Northrup built the company, raised $50 million in funding, received 15 issued patents, developed automated identification and monitoring systems for biological pathogen and forensic DNA applications. He sold the company in May 2011 to Positive ID Corporation (OB:PSID).
Dr. Northrup has 50 issued US and foreign patents, 40 peer-reviewed publications, and several engineering and entrepreneurial business awards. Dr. Northrup has been the Principal Investigator on over 85 million dollars of funding from US Government agencies, such as the Department of Homeland Security (DHS) and the Department of Defense (DoD). He co-invented numerous bio-analytical systems, including the commercial Cepheid Systems (SmartCycler and GenXpert). The latter was recently approved by the World Health Organization (WHO) for its tuberculosis test. Also Dr. Northrup has delivered numerous bio-analytical systems to DHS, DoD and the United Kingdom.
Dr. Northrup has made outstanding contributions to bio-analytical and actuator-based micro-technologies. He loves to build companies and has a strong entrepreneurial spirit.
He is currently the Science Advisor to 3 start-up companies in US and Europe.
Dr. Northrup earned his PhD in Biomedical Engineering from the University of California, Davis (UCD) in 1991. During his early years at UCD, Dr. Northrup worked for Finnigan Corporation, a manufacturer of Gas Chromatograph/Mass Spectrometers (GC/MS). As a Post-doctoral Fellow and Engineer at Lawrence Livermore National Laboratory (LLNL) and as a Visiting Scholar at the University of California, Berkeley (UCB), he was the first to demonstrate the Polymerase Chain Reaction (PCR) in a micro-machined silicon chip. At LLNL, he raised $12 M in funding and also invented and co-developed micro-actuators and micro-actuator materials, which includes over 30 patents.
As Co-Founder and CTO of Cepheid, he raised over $15M in R & D funding and was on the Initial Public Offering (IPO) team in FY 2000.
As CEO and Founder of Microfluidic Systems, Dr. Northrup built the company, raised $50 million in funding, received 15 issued patents, developed automated identification and monitoring systems for biological pathogen and forensic DNA applications. He sold the company in May 2011 to Positive ID Corporation (OB:PSID).
Dr. Northrup has 50 issued US and foreign patents, 40 peer-reviewed publications, and several engineering and entrepreneurial business awards. Dr. Northrup has been the Principal Investigator on over 85 million dollars of funding from US Government agencies, such as the Department of Homeland Security (DHS) and the Department of Defense (DoD). He co-invented numerous bio-analytical systems, including the commercial Cepheid Systems (SmartCycler and GenXpert). The latter was recently approved by the World Health Organization (WHO) for its tuberculosis test. Also Dr. Northrup has delivered numerous bio-analytical systems to DHS, DoD and the United Kingdom.
Dr. Northrup has made outstanding contributions to bio-analytical and actuator-based micro-technologies. He loves to build companies and has a strong entrepreneurial spirit.